Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan

Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan

Background: The recommended target low-density lipoprotein cholesterol (LDL-C) level for coronary artery disease (CAD) patients has been lowered from 100 to 70 mg/dL in several clinical guidelines for secondary prevention. We aimed to assess whether initiating statin treatment in CAD patients with b...

Full description

Bibliographic Details
Main Authors: Fang-Ju Lin, Kou-Gi Shyu, I-Chang Hsieh, Wayne Huey-Herng Sheu, Shih-Te Tu, Shoou-Jeng Yeh, Chin-I Chen, Kuo-Cheng Lu, Chia-Chao Wu, Wen-Yi Shau, Timothy J. Inocencio, Yao-Chun Wen, Hung-I Yeh
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Journal of the Formosan Medical Association
Subjects:
Statin
Secondary prevention
Low-density lipoprotein cholesterol
Coronary artery disease
Cost-effectiveness analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664620300140

Internet

http://www.sciencedirect.com/science/article/pii/S0929664620300140

Similar Items